Related Articles
Prognostic value of KRAS/TP53/PIK3CA in non‑small cell lung cancer
IDH1‑R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR
Molecular profile and clinical features of patients with gliomas using a broad targeted next generation‑sequencing panel
Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer
Genetic analysis of fundic gland‑type gastric adenocarcinoma